Anna Kearney‐Schwartz

1.5k total citations
36 papers, 1.0k citations indexed

About

Anna Kearney‐Schwartz is a scholar working on Cardiology and Cardiovascular Medicine, Pulmonary and Respiratory Medicine and Psychiatry and Mental health. According to data from OpenAlex, Anna Kearney‐Schwartz has authored 36 papers receiving a total of 1.0k indexed citations (citations by other indexed papers that have themselves been cited), including 23 papers in Cardiology and Cardiovascular Medicine, 10 papers in Pulmonary and Respiratory Medicine and 7 papers in Psychiatry and Mental health. Recurrent topics in Anna Kearney‐Schwartz's work include Cardiovascular Health and Disease Prevention (16 papers), Dementia and Cognitive Impairment Research (7 papers) and Cardiovascular Function and Risk Factors (7 papers). Anna Kearney‐Schwartz is often cited by papers focused on Cardiovascular Health and Disease Prevention (16 papers), Dementia and Cognitive Impairment Research (7 papers) and Cardiovascular Function and Risk Factors (7 papers). Anna Kearney‐Schwartz collaborates with scholars based in France, Italy and Nepal. Anna Kearney‐Schwartz's co-authors include Athanase Bénétos, P. Böhme, Bruno Guerci, Faı̈ez Zannad, P Drouin, Renaud Fay, Patrick Rossignol, Patrick Lacolley, Serge Bracard and Paolo Salvi and has published in prestigious journals such as Journal of the American College of Cardiology, Stroke and Hypertension.

In The Last Decade

Anna Kearney‐Schwartz

35 papers receiving 998 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Anna Kearney‐Schwartz France 18 597 209 149 133 131 36 1.0k
William Stevenson United States 17 561 0.9× 81 0.4× 118 0.8× 75 0.6× 97 0.7× 22 1.1k
Mustafa Kılıç Türkiye 13 341 0.6× 125 0.6× 188 1.3× 151 1.1× 45 0.3× 34 797
Costas Psarros Greece 15 490 0.8× 79 0.4× 212 1.4× 346 2.6× 66 0.5× 27 1.1k
Shinichi Wakabayashi Japan 19 238 0.4× 141 0.7× 100 0.7× 169 1.3× 34 0.3× 75 983
Franz Kehl Germany 26 494 0.8× 140 0.7× 148 1.0× 167 1.3× 101 0.8× 60 1.8k
Peter Kang United States 18 390 0.7× 123 0.6× 155 1.0× 132 1.0× 114 0.9× 37 1.4k
Takashi Matsumoto Japan 19 282 0.5× 123 0.6× 53 0.4× 179 1.3× 39 0.3× 76 992
R. S. Zimmerman United States 12 495 0.8× 171 0.8× 268 1.8× 103 0.8× 81 0.6× 19 1.0k
Thiago Quinaglia United States 14 450 0.8× 92 0.4× 91 0.6× 79 0.6× 149 1.1× 68 772

Countries citing papers authored by Anna Kearney‐Schwartz

Since Specialization
Citations

This map shows the geographic impact of Anna Kearney‐Schwartz's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Anna Kearney‐Schwartz with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Anna Kearney‐Schwartz more than expected).

Fields of papers citing papers by Anna Kearney‐Schwartz

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Anna Kearney‐Schwartz. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Anna Kearney‐Schwartz. The network helps show where Anna Kearney‐Schwartz may publish in the future.

Co-authorship network of co-authors of Anna Kearney‐Schwartz

This figure shows the co-authorship network connecting the top 25 collaborators of Anna Kearney‐Schwartz. A scholar is included among the top collaborators of Anna Kearney‐Schwartz based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Anna Kearney‐Schwartz. Anna Kearney‐Schwartz is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Doyen, Matthieu, Véronique Roch, Nathalie Thilly, et al.. (2024). 18F-FDG PET can effectively rule out conversion to dementia and the presence of CSF biomarker of neurodegeneration: a real-world data analysis. Alzheimer s Research & Therapy. 16(1). 182–182. 5 indexed citations
2.
Girerd, Nicolas, Anna Kearney‐Schwartz, Kévin Duarte, et al.. (2023). Levels of Procollagen Type I C-Terminal Pro-Peptide and Galectin-3, Arterial Stiffness Measured By Pulse Wave Velocity, and Cardiovascular Morbidity and Mortality in 44 Patients 2 Years After Kidney Transplantation. Annals of Transplantation. 28. e938137–e938137. 1 indexed citations
3.
Girerd, Nicolas, Anna Kearney‐Schwartz, Patrick Rossignol, et al.. (2022). Association between Long-Term Change in Arterial Stiffness and Cardiovascular Outcomes in Kidney Transplant Recipients: Insights from the TRANSARTE Study. Journal of Clinical Medicine. 11(5). 1410–1410. 5 indexed citations
4.
Triantafyllou, Αreti, João Pedro Ferreira, Masatake Kobayashi, et al.. (2020). Longer Duration of Hypertension and MRI Microvascular Brain Alterations Are Associated with Lower Hippocampal Volumes in Older Individuals with Hypertension. Journal of Alzheimer s Disease. 74(1). 227–235. 20 indexed citations
5.
Chawki, Mohammad B., Gabriela Hossu, Anna Kearney‐Schwartz, et al.. (2017). Cross-sectional variations of white and grey matter in older hypertensive patients with subjective memory complaints. NeuroImage Clinical. 17. 804–810. 8 indexed citations
6.
Verger, Antoine, Gabriela Hossu, Anna Kearney‐Schwartz, et al.. (2016). Grey-Matter Metabolism in Relation with White-Matter Lesions in Older Hypertensive Patients with Subjective Memory Complaints: A Pilot Voxel-Based Analysis Study. Cerebrovascular Diseases. 42(1-2). 106–109. 6 indexed citations
7.
Watfa, Ghassan, Athanase Bénétos, Anna Kearney‐Schwartz, et al.. (2015). Do Arterial Hemodynamic Parameters Predict Cognitive Decline Over a Period of 2 Years in Individuals Older Than 80 Years Living in Nursing Homes? The PARTAGE Study. Journal of the American Medical Directors Association. 16(7). 598–602. 17 indexed citations
8.
Eschalier, Romain, Patrick Rossignol, Anna Kearney‐Schwartz, et al.. (2014). Features of Cardiac Remodeling, Associated With Blood Pressure and Fibrosis Biomarkers, Are Frequent in Subjects With Abdominal Obesity. Hypertension. 63(4). 740–746. 48 indexed citations
9.
Temmar, M., Ghassan Watfa, Laure Joly, et al.. (2013). Elderly Algerian women lose their sex-advantage in terms of arterial stiffness and cardiovascular profile. Journal of Hypertension. 31(11). 2244–2250. 3 indexed citations
10.
Kerdjoudj, Halima, Tunay Kökten, Jean‐François Stoltz, et al.. (2013). Endothelialized and preconditioned natural umbilical arteries with long term patency open the route for future human uses. Clinical Hemorheology and Microcirculation. 54(3). 223–234. 15 indexed citations
11.
Watfa, Ghassan, George Soulis, Anna Kearney‐Schwartz, et al.. (2012). Relationship between tissue glycation measured by autofluorescence and pulse wave velocity in young and elderly non-diabetic populations. Diabetes & Metabolism. 38(5). 413–419. 17 indexed citations
12.
Eschalier, Romain, Anna Kearney‐Schwartz, Patrick Rossignol, et al.. (2012). Comprehensive MRI analysis of early cardiac and vascular remodeling in middle-aged patients with abdominal obesity. Journal of Hypertension. 30(3). 567–573. 17 indexed citations
13.
Dufour, B, Anna Kearney‐Schwartz, Laure Joly, et al.. (2012). Glomerular filtration rate estimated by Cockcroft-Gault formula better predicts anti-Xa levels than modification of the diet in renal disease equation in older patients with prophylactic enoxaparin. The journal of nutrition health & aging. 16(7). 647–652. 11 indexed citations
14.
Kearney‐Schwartz, Anna, et al.. (2011). Evolution of arterial stiffness after kidney transplantation. Nephrology Dialysis Transplantation. 26(10). 3386–3391. 21 indexed citations
15.
Watfa, Ghassan, Patrick Rossignol, Anna Kearney‐Schwartz, et al.. (2010). Association Study of Gene Polymorphisms Involved in Vascular Alterations in Elderly Hypertensives with Subjective Memory Complaints. Dementia and Geriatric Cognitive Disorders. 30(5). 440–448. 10 indexed citations
16.
Watfa, Ghassan, Patrick Rossignol, Anna Kearney‐Schwartz, et al.. (2010). Use of calcium channel blockers is associated with better cognitive performance in older hypertensive patients with subjective memory complaints. Journal of Hypertension. 28(12). 2485–2493. 20 indexed citations
17.
Alecu, Cosmin, Carlos Labat, Anna Kearney‐Schwartz, et al.. (2008). Reference values of aortic pulse wave velocity in the elderly. Journal of Hypertension. 26(11). 2207–2212. 47 indexed citations
18.
Bénétos, Athanase, A. Zervoudaki, Anna Kearney‐Schwartz, et al.. (2008). Effects of lean and fat mass on bone mineral density and arterial stiffness in elderly men. Osteoporosis International. 20(8). 1385–1391. 29 indexed citations
19.
Kearney‐Schwartz, Anna, Jean‐Marc Virion, Jean‐François Stoltz, Pierre Drouin, & Faı̈ez Zannad. (2007). Haemorheological disturbances in hypertensive type 2 diabetic patients – influence of antihypertensive therapy. Fundamental and Clinical Pharmacology. 21(4). 387–396. 16 indexed citations
20.
Alla, François, et al.. (2005). Early Changes in Serum Markers of Cardiac Extra-Cellular Matrix Turnover in Patients with Uncomplicated Hypertension and Type II Diabetes. European Journal of Heart Failure. 8(2). 147–153. 55 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026